JP2022511540A5 - - Google Patents
Info
- Publication number
- JP2022511540A5 JP2022511540A5 JP2021532155A JP2021532155A JP2022511540A5 JP 2022511540 A5 JP2022511540 A5 JP 2022511540A5 JP 2021532155 A JP2021532155 A JP 2021532155A JP 2021532155 A JP2021532155 A JP 2021532155A JP 2022511540 A5 JP2022511540 A5 JP 2022511540A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779907P | 2018-12-14 | 2018-12-14 | |
| US62/779,907 | 2018-12-14 | ||
| PCT/US2019/066413 WO2020124059A1 (en) | 2018-12-14 | 2019-12-14 | Tricyclic compounds as sting agonists, and preparation methods and medicinal uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022511540A JP2022511540A (ja) | 2022-01-31 |
| JP2022511540A5 true JP2022511540A5 (https=) | 2022-12-19 |
| JPWO2020124059A5 JPWO2020124059A5 (https=) | 2022-12-19 |
Family
ID=71077552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532155A Pending JP2022511540A (ja) | 2018-12-14 | 2019-12-14 | Ｓｔｉｎｇアゴニストとしての三環式化合物、ならびにその調製方法および医薬用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220056044A1 (https=) |
| EP (1) | EP3873896A4 (https=) |
| JP (1) | JP2022511540A (https=) |
| CN (1) | CN113195473B (https=) |
| TW (1) | TW202039508A (https=) |
| WO (1) | WO2020124059A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111655682B (zh) * | 2018-08-29 | 2024-05-31 | 杭州阿诺生物医药科技有限公司 | 一种高活性sting蛋白激动剂化合物 |
| WO2021206158A1 (ja) | 2020-04-10 | 2021-10-14 | 小野薬品工業株式会社 | がん治療方法 |
| CN119110800A (zh) * | 2022-02-21 | 2024-12-10 | 健道生物医药有限公司 | 干扰素基因刺激因子（sting）调节剂及其组合物和方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2747678B1 (fr) * | 1996-04-22 | 1998-05-22 | Synthelabo | Composes derives d'imidazobenzoxazine, leurs procedes de preparation et leurs utilisations en therapeutique |
| ECSP003637A (es) * | 1999-08-31 | 2002-03-25 | Agouron Pharma | Inhibidores triciclicos de poli (adp-ribosa) polimerasas |
| KR20080035576A (ko) * | 2005-08-05 | 2008-04-23 | 아스트라제네카 아베 | 트리사이클릭 벤즈이미다졸 및 대사체 글루타메이트 수용체조절제로서 이들의 용도 |
| GB201220157D0 (en) * | 2012-11-08 | 2012-12-26 | Selvita Sa | Substitute tricyclic benzimidazoles as kinase inhibitors |
| MX366703B (es) * | 2013-03-15 | 2019-07-22 | Incyte Holdings Corp | Heterociclos tricíclicos como inhibidores de la proteína bet. |
| HRP20220936T1 (hr) * | 2016-04-07 | 2022-10-28 | Glaxosmithkline Intellectual Property Development Limited | Heterociklički amidi korisni kao modulatori proteina |
| JP2021530442A (ja) * | 2018-06-28 | 2021-11-11 | ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co., Ltd. | 縮合三環系複素環化合物およびその治療上の使用 |
| CN111655682B (zh) * | 2018-08-29 | 2024-05-31 | 杭州阿诺生物医药科技有限公司 | 一种高活性sting蛋白激动剂化合物 |
-
2019
- 2019-12-14 WO PCT/US2019/066413 patent/WO2020124059A1/en not_active Ceased
- 2019-12-14 EP EP19895133.7A patent/EP3873896A4/en not_active Withdrawn
- 2019-12-14 US US17/413,287 patent/US20220056044A1/en not_active Abandoned
- 2019-12-14 CN CN201980081825.1A patent/CN113195473B/zh active Active
- 2019-12-14 JP JP2021532155A patent/JP2022511540A/ja active Pending
- 2019-12-16 TW TW108146054A patent/TW202039508A/zh unknown